List view / Grid view
The company will start enrolment to the Ad26.COV2-S vaccine trial…
The company will start enrolment to the Ad26.COV2-S vaccine trial next week, it anticipates initial results in September.
Johnson & Johnson announced that its affiliate Janssen Pharmaceutica NV…
30 April 2014 | By Johnson & Johnson
Johnson & Johnson announced that its affiliate Janssen Pharmaceutica NV has entered into a novel collaboration with the Stichting International Dispensary Association...
Janssen global public health to oversee R&D and access strategy…
22 January 2014 | By Johnson & Johnson
Janssen global public health to oversee R&D and access strategy development for growing portfolio of transformational medicines...
Sub-Saharan African Ministries of Health invited to submit expression of…
9 December 2013 | By Johnson & Johnson
Sub-Saharan African Ministries of Health invited to submit expression of interest to participate in new effort donation program to be part of broader initiative to raise awareness and action...
Collaborations announced between regional innovators and Johnson & Johnson family…
3 October 2013 | By Johnson & Johnson
Collaborations announced between regional innovators and Johnson & Johnson family of companies...
3 – 4 December 2013, The InterContinental Park Lane, London...
6 August 2013 | By Financial Times
3 – 4 December 2013, The InterContinental Park Lane, London...
FDA has granted accelerated approval to SIRTURO™ Tablets for the…
31 December 2012 | By Johnson & Johnson
FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis...
